TFX Total Utang marang Modal teleflex.com

TFX (Teleflex Inc) - tandha merek perusahaan

Teleflex Incorporated (TFX) specializes in developing surgical equipment and vascular access systems for clinics, expanding its footprint through M&A transactions. This price trend chart confirms the financial standing, where the debt-to-equity ratio stands at 1.06. However, product defect lawsuits and stringent regulatory oversight are creating pressure. The company has currently reached its operational efficiency ceiling and is now pursuing growth through premium products.

teleflex.com (TFX) - Koefisien Total Utang marang Modal saka 04.07.2022 nganti 27.10.2026

Rincian metrik komprehensif lan analitis Teleflex Corp (TFX)

- rega lan prakiraan konsensus rega:
Rega saham Teleflex|TFX - Rata-rata rega prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Teleflex|TFX - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Teleflex|TFX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku teleflex.com|TFX - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Teleflex Incorporated|TFX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Teleflex Incorporated|TFX - Utang perusahaan|Utang marang nilai buku Teleflex
Analisis komprehensif perusahaan:TFX - Teleflex
Produk dadi Teleflex Incorporated

Maintaining a balance of borrowed funds is critical for Teleflex Incorporated (TFX) amid regulatory risks and potential litigation costs stemming from medical device defects. By analyzing the debt-to-equity ratio, investors assess the level of leverage relative to equity: a downward trend confirms financial stability, while an increase indicates a dangerous reliance on external loans during business expansion.

Pesaing utama

Total Utang marang Modal ISRG (Intuitive)|Utang marang Modal Danaher Corporation|Total Utang marang Modal Becton, Dickinson and Company BDX|Rasio Utang marang Ekuitas STERIS Group (STE)|Total Utang marang Modal WST|Koefisien Total Utang marang Modal baxter.com BAX|MASI: Total Utang marang Modal|STVN - Rasio Total Utang marang Ekuitas|MMSI: Total Utang marang Modal|NVST (Nobel Biocare) - Total Utang marang Modal|Utang marang Ekuitas ICU Medical, Inc.|Utang marang Ekuitas dentsplysirona.com (XRAY)|LeMaitre Vascular (LMAT) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AtriCure Inc (ATRC)|Total Utang marang Modal STAA|ChromaDex - Koefisien Total Utang marang Modal|ZimVie Inc. (ZIMV) - Utang marang Ekuitas|ANGO: Rasio Utang marang Ekuitas|Cerus - Utang marang Ekuitas|Koefisien Total Utang marang Modal Alpha Teknova|Monogram Technologies Inc (MGRM) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal STSS|InfuSystem Holdings (INFU) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi utahmed.com UTMD|Rasio Total Utang marang Ekuitas KRMD (KORU Medical)|Nyxoah SA - Total Utang marang Modal|MBOT: Utang marang Ekuitas|PDEX - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZTEK|ELUT (elutia.com) - Utang marang Modal|Utang marang Ekuitas Milestone Scientific Inc. (MLSS)|Rasio Utang marang Ekuitas NEXGEL Inc. (NXGL)|Rasio Total Utang marang Ekuitas Retractable Technologies|Utang Agregat marang Modal HBIO (harvardbioscience.com)|Utang marang Ekuitas FEMY|MHUA - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas Predictive Oncology Corp POAI|CJMB - Utang Agregat marang Modal|Total Utang marang Modal ATRI|NURO (NeuroMetrix Corporation) - Utang marang Modal